מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)
Atlantis Consumer Healthcare, Inc.
ORAL
OTC DRUG
Laxative Uses - relieves occasional constipation (irregularity) - generally produces a bowel movement in 6–12 hours Do not use - laxative products for longer than 1 week unless directed by a doctor Stop use and ask a doctorif you have rectal bleeding or fail to have a bowel movementafter use of a laxative. These may indicate a serious condition.
OTC monograph not final
SENOKOT- STANDARDIZED SENNA CONCENTRATE TABLET ATLANTIS CONSUMER HEALTHCARE, INC. ---------- SENOKOT _(STANDARDIZED SENNA CONCENTRATE)_ _DRUG FACTS_ _ACTIVE INGREDIENT (IN EACH TABLET)_ Sennosides 8.6mg _PURPOSE_ Laxative _USES_ relieves occasional constipation (irregularity) generally produces a bowel movement in 6–12 hours _WARNINGS_ DO NOT USE laxative products for longer than 1 week unless directed by a doctor ASKA DOCTOR BEFORE USE IF YOU HAVE stomach pain nausea vomiting noticed a sudden change in bowel habits that continues overa period of 2 weeks STOP USE AND ASK A DOCTORIF you have rectal bleeding or fail to have a bowel movementafter use of a laxative. These may indicate a serious condition. IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison ControlCenter right away. _DIRECTIONS_ take preferably at bedtime or as directed by a doctor AGE STARTING DOSAGE MAXIMUM DOSAGE adults and children 12 years of age and over 2 tablets oncea day 4 tablets twicea day children 6 to under12 years 1 tablet once aday 2 tablets twicea day children 2 to under6 years 1/2 tablet oncea day 1 tablet twicea day children under2 years ask a doctor ask a doctor _OTHER INFORMATION_ EACH TABLET CONTAINS: calcium 20 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) _INACTIVE INGREDIENTS_ croscarmellose sodium, dicalciumphosphate, hypromellose, magnesium stearate, maltodextrin, microcrystallinecellulose, mineral oil, polyethylene glycol, talc ©2020 Avrio Health L.P. 305616-0B 50 Tablets NDC 67618-300-50 100 Tablets NDC 67618-300-10 SENOKOT standardized senna concentrate tablet PRODUCT INFORMATION PRODUCT TYPE HUMAN OTC DRUG ITEM CODE (SOURCE) NDC:67618-300 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH CROSCARMELLOSE SOD קרא את המסמך השלם